Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer

Clinical trial NCT01348009 · UNKNOWN

Trial details

NCT number: NCT01348009
Sponsor: Genta Incorporated
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gastric Carcinoma

Start date: 2011-05-01
Primary completion: 2013-10-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.